132 related articles for article (PubMed ID: 7594346)
1. Lansoprazole for maintenance therapy of peptic ulcer disease: weekend full-dose or everyday half-dose administration?
Hoshino E; Umeda N; Sano J; Miki K; Yahagi N; Oka M; Kimura M; Miyashita H
J Clin Gastroenterol; 1995; 20 Suppl 2():S72-4. PubMed ID: 7594346
[TBL] [Abstract][Full Text] [Related]
2. Effect of lansoprazole on peptic ulcers.
Ohashi T; Sakata J; Haraguchi Y; Eto T
J Clin Gastroenterol; 1995; 20 Suppl 2():S83-5. PubMed ID: 7594350
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
Katoh M; Asaka M; Kudoh M; Kagaya H; Katagiri M; Takeda H
J Clin Gastroenterol; 1995; 20 Suppl 2():S112-4. PubMed ID: 7594324
[TBL] [Abstract][Full Text] [Related]
4. Quality of peptic ulcer healing induced by lansoprazole and roxatidine.
Fujino MA; Morozumi A; Kobayashi K; Ueda F; Suzuki Y; Uchida N; Tachikawa H; Sano S; Ohtsuka H; Yamamoto Y
J Clin Gastroenterol; 1995; 20 Suppl 2():S44-6. PubMed ID: 7594338
[TBL] [Abstract][Full Text] [Related]
5. Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor.
Kaneko E; Hoshihara Y; Sakaki N; Harasawa S; Ashida K; Asaka M; Asaki S; Nakamura T; Kobayashi K; Kajiyama G; Ogawa N; Yao T; Muto Y; Nakazawa S; Takemoto T
J Gastroenterol; 2000; 35(11):824-31. PubMed ID: 11085491
[TBL] [Abstract][Full Text] [Related]
6. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
Sugiyama T; Hisano K; Ochiai T; Fujita N; Kobayashi T; Yabana T; Kurokawa I; Yachi A
J Clin Gastroenterol; 1995; 20 Suppl 2():S104-6. PubMed ID: 7594322
[TBL] [Abstract][Full Text] [Related]
7. Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori.
Furuta T; Futami H; Arai H; Hanai H; Kaneko E
J Clin Gastroenterol; 1995; 20 Suppl 2():S107-11. PubMed ID: 7594323
[TBL] [Abstract][Full Text] [Related]
8. An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Brunner G; Arnold R; Hennig U; Fuchs W
Aliment Pharmacol Ther; 1993; 7 Suppl 1():51-5, discussion 61-6. PubMed ID: 8490080
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer.
Kovacs TO; Campbell D; Haber M; Rose P; Jennings DE; Richter J
Dig Dis Sci; 1998 Apr; 43(4):779-85. PubMed ID: 9558034
[TBL] [Abstract][Full Text] [Related]
10. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
11. [Lansoprazole--profile of a new proton pump inhibitor].
Seifert E
Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
[TBL] [Abstract][Full Text] [Related]
12. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H2-receptor antagonists.
Kovacs TO; Campbell D; Richter J; Haber M; Jennings DE; Rose P
Aliment Pharmacol Ther; 1999 Jul; 13(7):959-67. PubMed ID: 10383532
[TBL] [Abstract][Full Text] [Related]
13. The effect of lansoprazole treatment on the healing and relapse of peptic ulcer and serum levels of IgG anti-Helicobacter pylori antibody.
Mine T; Yasuda H; Akimoto K; Katoaka A; Mashima H; Tajima A; Fukujin H; Tsuchida T; Takano T; Nagasawa J
J Clin Gastroenterol; 1995; 20 Suppl 2():S75-8. PubMed ID: 7594347
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
Ramón Nogueira J; Esquivel Ayanegui F; Esquivel Rodríguez F; Sáenz V; Santoyo R
Rev Gastroenterol Mex; 1996; 61(4):314-9. PubMed ID: 9072782
[TBL] [Abstract][Full Text] [Related]
15. Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
Ogoshi K; Kato T; Sakagawa T
J Clin Gastroenterol; 1995; 20 Suppl 2():S97-9. PubMed ID: 7594354
[TBL] [Abstract][Full Text] [Related]
16. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
17. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
18. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting quality of ulcer healing after lansoprazole treatment.
Ito G; Nakagawara M; Watanabe F; Ooi S; Nawano M; Hanai H; Kaneko E
J Clin Gastroenterol; 1995; 20 Suppl 2():S62-6. PubMed ID: 7594344
[TBL] [Abstract][Full Text] [Related]
20. Eradication of Helicobacter pylori with lansoprazole, amoxicillin, and plaunotol in duodenal ulcer patients.
Shirai T; Takagi A; Kurumada T; Ohta U; Kobayashi H; Harasawa S; Miwa T
J Clin Gastroenterol; 1995; 20 Suppl 2():S128-31. PubMed ID: 7594329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]